WithdrawnNot applicableNCT01986764

E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy

Studying Infantile neuroaxonal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Pennsylvania
Principal Investigator
C. Neill Epperson, MD
University of Pennsylvania
Intervention
Lisdexamfetamine(drug)
Eligibility
30-48 years · FEMALE
Timeline
20132013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01986764 on ClinicalTrials.gov

Other trials for Infantile neuroaxonal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Infantile neuroaxonal dystrophy

← Back to all trials